首页/数据集/Dataset from A Phase 3, Multicenter, Double-Blind, Randomized, Placebo-Controlled Study Evaluating the Efficacy of SAGE-217 in the Treatment of Adult Subjects With Major Depressive Disorder

Dataset from A Phase 3, Multicenter, Double-Blind, Randomized, Placebo-Controlled Study Evaluating the Efficacy of SAGE-217 in the Treatment of Adult Subjects With Major Depressive Disorder

NIAID Data Ecosystem2026-05-02 收录

抑郁症药物临床试验

抑郁治疗评估

数据链接：

https://doi.org/10.25934/PR00010566 数据链接链接失效反馈

官方服务：

资源简介：

The purpose of this study to evaluate the efficacy of SAGE-217 in the treatment of participants with MDD.

应用场景：

创建时间：

2025-05-18

抑郁治疗评估

HAM-D6评分分析

Abbreviations: HAM-D6 = Hamilton Depression Rating Scale, NA = not applicable, SE = standard error, CL = confidence limits.

Figshare2015-12-02 更新30

Details of 6 Studies of Medication and Placebo for Depressed Outparticipants (Table 1 of Fournier et al., 2010).

抑郁症药物临床试验

安慰剂对照研究

Abbreviations: F–ITT, full intent to treat; HDRS, Hamilton Depression Rating Scale; MDD, major depressive disorder; Minor, minor depressive disorder; M–ITT, modified intent to treat. aThe Barrett et a

NIAID Data Ecosystem20

A Phase 3, Randomized, Placebo-Controlled, Double-Blind, Parallel-Design Study to Evaluate the Short-Term, Fixed Dose Efficacy and Safety of LY110140 Once Daily Dosing in Japanese Patients With Major Depressive Disorder

抑郁症药物临床试验

抑郁症治疗

The purpose of this study is to evaluate the short-term efficacy and safety of Fluoxetine in Japanese adult participants with Major Depressive Disorder (MDD).

DataCite Commons2025-11-24 更新10

Characteristics of each rTMS study included.

经颅磁刺激

抑郁治疗评估

rTMS = repetitive transcranial magnetic stimulation; AD = antidepressant drug; HDRS = Hamilton Depression Rating Scale; MADRS = Montgomory-Asberg Depression Rating Scale; N/A = data not available.

NIAID Data Ecosystem30

Dataset from A Phase 3, Randomized, Double-Blind Study Comparing the Efficacy and Safety of SAGE-217 Plus an Antidepressant Versus Placebo Plus an Antidepressant in Adults With Major Depressive Disorder

抑郁症药物临床试验

精神科药物

The primary purpose of this study is to evaluate the efficacy of SAGE-217 plus an ADT in the treatment of major depressive disorder (MDD) compared to placebo plus an ADT.

NIAID Data Ecosystem20

Dataset from A Phase 3, Multicenter, Double-Blind, Randomized, Placebo-Controlled Study Evaluating the Efficacy of SAGE-217 in the Treatment of Adult Subjects With Major Depressive Disorder

资源简介：

相关数据集